Effects of coenzyme Q10 supplementation on lipid profiles and liver enzymes of nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta …
As an antioxidant, coenzyme Q 10 (CoQ10) has been proposed as a possible treatment for
non‐alcoholic fatty liver disease (NAFLD). In the present meta‐analysis, we aimed to …
non‐alcoholic fatty liver disease (NAFLD). In the present meta‐analysis, we aimed to …
Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver …
F Farsi, M Mohammadshahi, P Alavinejad… - Journal of the …, 2016 - Taylor & Francis
Background: Nonalcoholic fatty liver disease (NAFLD) is a chronic liver disorder related to
inflammation. Coenzyme Q10 (CoQ10) is a natural compound that has recently been …
inflammation. Coenzyme Q10 (CoQ10) is a natural compound that has recently been …
Cubosomes as a potential oral drug delivery system for enhancing the hepatoprotective effect of coenzyme Q10
AM Mohsen, MM Younis, A Salama… - Journal of Pharmaceutical …, 2021 - Elsevier
Abstract Coenzyme Q10 (CoQ10) acts as an antioxidant that protects the cells by preventing
lipid peroxidation. Owing to its low solubility, CoQ10 has shown poor delivery properties and …
lipid peroxidation. Owing to its low solubility, CoQ10 has shown poor delivery properties and …
The effect of coenzyme Q10 supplementation on liver enzymes: A systematic review and meta‐analysis of randomized clinical trials
M Soleimani Damaneh, S Fatahi… - Food Science & …, 2023 - Wiley Online Library
Coenzyme Q10 is a potent antioxidant and is necessary for energy production in
mitochondria. Clinical data have suggested that coenzyme Q10 (CoQ10) has some …
mitochondria. Clinical data have suggested that coenzyme Q10 (CoQ10) has some …
Oral coenzyme Q10 supplementation in patients with nonalcoholic fatty liver disease: effects on serum vaspin, chemerin, pentraxin 3, insulin resistance and oxidative …
Backgrounds and Aims Nonalcoholic fatty liver disease (NAFLD) is the most common cause
of chronic liver injury. Chronic exposure to oxidative stress leads to depletion of liver …
of chronic liver injury. Chronic exposure to oxidative stress leads to depletion of liver …
Chlorogenic acid, quercetin, coenzyme Q10 and silymarin modulate Keap1-Nrf2/heme oxygenase-1 signaling in thioacetamide-induced acute liver toxicity
RM Hussein, DM Sawy, MA Kandeil, HS Farghaly - Life Sciences, 2021 - Elsevier
Background and aims The normal functioning of Kelch-like ECH-associated protein-1
(Keap1)/nuclear factor erythroid 2-related factor 2 (Nrf2) complex is necessary for the …
(Keap1)/nuclear factor erythroid 2-related factor 2 (Nrf2) complex is necessary for the …
Protective effects of coenzyme Q10 nanoparticles on dichlorvos‐induced hepatotoxicity and mitochondrial/lysosomal injury
A Eftekhari, E Ahmadian, A Azami… - Environmental …, 2018 - Wiley Online Library
Abstract Development of biocompatible antioxidant nanoparticles for xenobiotic‐induced
liver disease treatment by oral or parenteral administration is of great interest in medicine. In …
liver disease treatment by oral or parenteral administration is of great interest in medicine. In …
[HTML][HTML] Comparative Assessment of Beeswax Alcohol and Coenzyme Q10 (CoQ10) to Prevent Liver Aging, Organ Damage, and Oxidative Stress in Hyperlipidemic …
The current study was designed to compare in vivo efficacy between beeswax alcohol
(BWA) and coenzyme Q10 (CoQ10) to treat fatty liver changes, oxidative stress, and …
(BWA) and coenzyme Q10 (CoQ10) to treat fatty liver changes, oxidative stress, and …
[HTML][HTML] Coenzyme Q10 attenuates lung and liver fibrosis via modulation of autophagy in methotrexate treated rat
The present study was conducted to investigate the potential protective effects of coenzyme
Q 10 (CoQ10) administration on methotrexate induced lung and liver fibrosis in rat model …
Q 10 (CoQ10) administration on methotrexate induced lung and liver fibrosis in rat model …
L-carnitine and Co Q10 ameliorate potassium dichromate-induced acute brain injury in rats targeting AMPK/AKT/NF-κβ
A Salama, R Elgohary - International Immunopharmacology, 2021 - Elsevier
Adenosine monophosphate-activated protein kinase (AMPK) has a crucial role in
neuroprotection. It phosphorylates serine/threonine kinase (Akt) Substrate inhibiting the …
neuroprotection. It phosphorylates serine/threonine kinase (Akt) Substrate inhibiting the …